Ä¢¹½ÊÓƵ

MITSUBISHI CHEMICAL GROUP
MITSUBISHI CHEMICAL GROUP

MT -2766, the world's first plant-based COVID -19 vaccine candidate Application for approval was submitted in Canada.

December 17, 2021

Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka; President: Hiroaki Ueno), an operating company of Mitsubishi Chemical Holdings Corporation (Head Office: Tokyo; President: Jean-Marc Gilson), announced today an application for approval in Canada for MT-2766, a COVID 19 vaccine candidate as follows.

Mitsubishi Tanabe Pharma¡¡Press Release

?Information is current as of the date of issue of the individual press release. Please be advised that information may be outdated after that point.

Back to top